. 2019 Mar 30;33(2):523–544. doi: 10.1016/j.idc.2019.02.004

Table 1.

Incidence of viral infections, rate of lower respiratory tract infection at diagnosis, and mortality rates for respiratory viral infections

Respiratory Virus	Incidence (%)	Lower Respiratory Tract Infection at Diagnosis (%)	Mortality (%)^c
Influenza A/B	1.3–401, 3, 4, 5, 6, 7, 8, 9^,^a	7–442, 3, 4, 5, 6, 7, 8, 10^,^a	8–281, 2, 3, 5, 7, 8, 10^,^a
PIV	3–274, 6, 11, 12^,^a	7–502, 4, 5, 8, 13, 14, 15^,^a	10–501, 2, 6, 8, 12, 14^,^a
RSV	1–501, 3, 4, 6, 16, 17^,^a	14–702, 3, 4, 5^,^a	11–473, 5, 6, 8, 17, 18^,^a
HMPV	2–111, 2, 3, 4, 19, 20^,^b	5-412, 4, 8, 20, 21^,^b	6–402, 19, 20, 21^,^b
Adenovirus	1–301, 2, 4, 8, 22, 23, 24^,^a	14–422, 3, 22, 23^,^a	14–732, 8, 22, 23^,^a
Rhinovirus	2–341, 2, 4, 8, 25^,^a	<5–272, 4, 8, 26^,^a	<5–412, 26, 27^,^a
CoV	3–231, 2, 4, 25, 28^,^b	<52, 4, 8^,^b	<5–542, 28^,^b
Bocavirus	1–32, 25, 29, 30^,^b	02, 8, 25, 30^,^b	Not reported25, 29, 30^,^d

Studies are a combination of PCR and traditional laboratory methods (eg, culture, direct fluorescent antibody, and enzyme immunoassay).

PCR-based studies.

Includes all-cause and attributable mortality with variable timeframe to death.

One mortality in a coinfected patient attributed to enterovirus/rhinovirus infection.